These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2420968)
61. [Circulatory dynamics after injection of high doses of human hypotensive polypeptide fractions]. Duck HJ; Köhler H; Günther K Z Gesamte Inn Med; 1979 Sep; 34(18):547-55. PubMed ID: 516841 [No Abstract] [Full Text] [Related]
62. Structure of human carboxypeptidase N (kininase I). Skidgel RA; Weerasinghe DK; Erdös EG Adv Exp Med Biol; 1989; 247A():325-9. PubMed ID: 2603798 [No Abstract] [Full Text] [Related]
63. Large scale preparation of N-carboxypeptidase (kininase I) as by-product of routine fractionation. Granier C; Fondacci M; Steinbuch M Adv Biosci; 1978 Jul; 17():65-71. PubMed ID: 755709 [No Abstract] [Full Text] [Related]
65. Purification and characterization of a kininase from human urine. Figueiredo AF; Marquezini AJ Adv Exp Med Biol; 1979; 120B():589-97. PubMed ID: 117682 [TBL] [Abstract][Full Text] [Related]
66. Kinin-destroying (kininase) activity on cultured rodent fibroblasts L-929. Back N; Steger R Proc Soc Exp Biol Med; 1976 Oct; 153(1):175-9. PubMed ID: 11496 [No Abstract] [Full Text] [Related]
67. Enkephalin convertase: potent, selective, and irreversible inhibitors. Fricker LD; Plummer TH; Snyder SH Biochem Biophys Res Commun; 1983 Mar; 111(3):994-1000. PubMed ID: 6404277 [TBL] [Abstract][Full Text] [Related]
69. A micromethod for the determination of the activities of kininases in rat plasma. Kinetics and inhibitory characteristics. Barabé J; Huberdeau D Biochem Pharmacol; 1991 Mar; 41(5):821-7. PubMed ID: 1847816 [TBL] [Abstract][Full Text] [Related]
70. Tissue plasminogen activator release in vivo in response to vasoactive agents. Smith D; Gilbert M; Owen WG Blood; 1985 Oct; 66(4):835-9. PubMed ID: 3929859 [TBL] [Abstract][Full Text] [Related]
71. [Changes in the content of bradykininogen and kininase activity of rat plasma in allergoid edema and thrombohemorrhages]. Ogorodova TS Patol Fiziol Eksp Ter; 1975; (1):40-3. PubMed ID: 1143939 [No Abstract] [Full Text] [Related]
72. VASOPRESSOR RESPONSES TO KALLIDIN, BRADYKININ AND ELEDOISIN IN HYPOTENSIVE RATS. PARRATT JR J Pharm Pharmacol; 1964 Feb; 16():132-3. PubMed ID: 14119540 [No Abstract] [Full Text] [Related]
73. A study of kininase activity in pig liver [proceedings]. Sharma RK; Dearnley CN; Bailey GS Biochem Soc Trans; 1979 Oct; 7(5):1061-3. PubMed ID: 556229 [No Abstract] [Full Text] [Related]
74. Kininase and anti-inflammatory activities of acid carboxypeptidase from Penicillium janthinellum. Yokoyama S; Oobayashi A; Tanabe O; Ohata K; Shibata Y Experientia; 1975 Oct; 31(10):1122-4. PubMed ID: 1204716 [TBL] [Abstract][Full Text] [Related]
75. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Yang HY; Erdös EG; Levin Y Biochim Biophys Acta; 1970 Aug; 214(2):374-6. PubMed ID: 4322742 [No Abstract] [Full Text] [Related]
76. Synthetic inhibitors of carboxypeptidase N. Fisher GH; Ryan JW; Chung A; Plumer TH Adv Exp Med Biol; 1986; 198 Pt A():405-10. PubMed ID: 3812090 [TBL] [Abstract][Full Text] [Related]
77. Fluorescence Probes for Imaging Basic Carboxypeptidase Activity in Living Cells with High Intracellular Retention. Iwaki H; Kamiya M; Kawatani M; Kojima R; Yamasoba T; Urano Y Anal Chem; 2021 Feb; 93(7):3470-3476. PubMed ID: 33566568 [TBL] [Abstract][Full Text] [Related]